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Abstract 
 Emergency presentation is recognized to be associated with poorer cancer specific 
survival following curative resection for colorectal cancer.  The present study examined the 
hypothesis that an enhanced systemic inflammatory response, prior to surgery, might explain 
the impact of emergency presentation on survival.  In all, 188 patients undergoing potentially 
curative resection for colorectal cancer were studied.  Of these, 55 (29%) presented as 
emergencies.  The systemic inflammatory response was assessed using the Glasgow 
Prognostic Score (mGPS) which is the combination of an elevated C-reactive protein 
(>10mg/l) and hypoalbuminaemia (<35g/l).  In the emergency group, tumour stage was 
greater (p<0.01), more patients received adjuvant therapy (p<0.01) more patients had an 
elevated mGPS (p<0.01) and more patients died of their disease (p<0.05).  The minimum 
follow-up was 12 months; the median follow-up of the survivors was 48 months. Emergency 
presentation was associated with poorer 3 year cancer specific survival in those patients aged 
65-74 years (p<0.01), males and females (p<0.05), in the deprived (p<0.01), in TNM stage II 
(p<0.01), in no adjuvant therapy (p<0.01) disease and in the mGPS 0 and 1 (p<0.05) groups. 
On multivariate survival analysis of those patients undergoing potentially curative surgery for 
TNM stage II colon cancer, emergency presentation (p<0.05) and the mGPS (p<0.05) were 
independently associated with cancer specific survival.  Therefore, these results suggest that 
emergency presentation and the presence of systemic inflammatory response prior to surgery 
are linked and account for poorer cancer specific survival in patients undergoing potentially 
curative surgery for colon cancer.  Both emergency presentation and an elevated mGPS 
should be taken into account when assessing likely outcome of these patients. 
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Introduction 
Colorectal cancer remains the second commonest cause of cancer death in Western 
Europe and North America.  Each year in the UK, there are approximately 35,000 new cases 
and 16,000 deaths attributable to the disease (1).   
It has long been recognized that emergency presentation is associated with high 
postoperative mortality rate (2-4).  Furthermore, not only is emergency presentation associated 
with higher post-operative mortality but, compared to those who undergo elective curative 
resection, there is also a reduction in overall and cancer specific survival (3,4).  In particular, 
emergency presentation is a feature of colon cancer(4) and predicts poorer cancer specific 
survival independent of other clinicopathological factors including tumour stage(5).  
The reasons for the increase in cancer specific mortality in those colon cancer patients 
who present as an emergency are not clear.  However, the presence of a systemic 
inflammatory response prior to surgery, as evidenced by an elevated C-reactive protein 
concentration or hypoalbuminaemia, predicts overall and cancer specific survival, 
independent of stage, in patients undergoing potentially curative resection for both colon and 
rectal cancer (6-8).   
We have recently combined C-reactive protein and albumin to form a new score, the 
Glasgow Prognostic score (GPS, recently modified to mGPS), which has prognostic value, 
independent of stage, in patients with advanced or primary operable cancer (9,10).  Since it is 
likely that emergency presentation would be associated with a pre-operative systemic 
inflammatory response, it may be that the mGPS might explain the impact of emergency 
presentation on cancer specific survival (5).  To our knowledge no previous study has 
examined the relationship between emergency presentation, the systemic inflammatory 
response and cancer specific survival in patients undergoing potentially curative resection for 
colon cancer. 
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Therefore, the aim of the present study was to examine the relationship between 
emergency presentation, the pre- operative mGPS and cancer specific survival in patients 
undergoing curative resection for colon cancer. 
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Patients and Methods  
Patients 
Patients with histologically proven colon cancer who, on the basis of laparotomy 
findings and preoperative abdominal computed tomography, were considered to have 
undergone a potentially curative resection between November 1999 and August 2006 in a 
single surgical unit at Glasgow Royal Infirmary and in whom C-reactive protein and albumin 
were measured prior to surgery were prospectively included in the study. 
For the purpose of this analysis, outcome in patients who presented as an emergency 
with evidence of blood loss, obstruction or perforation was compared with those patients 
admitted for elective surgery (5). 
The extent of deprivation was defined using the Carstairs deprivation index (11).  This 
is an area-based measure derived from the 1991 census, using the postcode of residence at 
diagnosis, which divides the score into a seven-point index.  For illustrative purposes, the 
results are presented by amalgamating the seven categories into three groups: affluent 
(categories 1 and 2), intermediate (categories 3–5) and deprived (categories 6 and 7).  The 
Carstairs deprivation index has been extensively utilised in cancer patients and is particularly 
appropriate for use in the central belt of Scotland (12).  
The tumours were staged using the conventional TNM classification (13).  Patients who 
had neo-adjuvant therapy or who died within 30 days of surgery were excluded from the 
study.   
The study was approved by the Research Ethics Committee, Royal Infirmary, 
Glasgow.  
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 Methods 
Routine laboratory measurements of C-reactive protein and albumin at the time of 
diagnosis were carried out. The limit of detection of the C-reactive protein assay was <6mg/l.  
The coefficients of variation of these methods, over the range of measurements, was less than 
5% as established by routine quality control. 
The GPS was constructed as previously described (14).  Briefly, patients with both an 
elevated C-reactive protein (>10 mg/l) and hypoalbuminaemia (<35g/l) were allocated a score 
of 2.  Patients in whom only one of these biochemical abnormalities was present were 
allocated a score of 1.  Patients in whom neither of these abnormalities was present were 
allocated a score of 0.   
Recently, this has been modified based on evidence that hypoalbuminaemia, in 
patients without an elevated C-reactive protein concentration, had no significant association 
with cancer specific survival.  Therefore, patients with an elevated C-reactive protein were 
assigned a modified GPS score (mGPS) of 1 or 2 depending on the absence or presence of 
hypoalbuminaemia (9). 
 
Statistics 
 Comparisons between groups of patients were carried out using contingency table 
analysis (X2) as appropriate. Deaths to the end of August 2007 were included in the analysis. 
The percentages of patients surviving 3years were calculated using the Kaplan-Meier 
technique.  Survival analysis of the group variables was performed using the Cox proportional 
hazard model. Multivariate survival analysis was performed using a stepwise backward 
procedure to derive a final model of the variables that had a significant independent 
relationship with survival.  To remove a variable from the model, the corresponding p-value 
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had to be >0.10.  Analysis was performed using SPSS software (SPSS Inc., Chicago, IL, 
USA). 
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Results 
The baseline characteristics of the 188 patients who underwent potentially curative 
resection for colon cancer are shown in Table 1.  The majority of patients were male, aged 65 
years or more, were deprived and had TNM stage I or II disease. 
One hundred and nine (58%) patients had an elevated C-reactive protein concentration 
(>10 mg/l) and 34 (18%) patients had hypoalbuminaemia prior to surgery.  Of the 34 patients 
with hypoalbuminaemia, 30 (88%) had an elevated C-reactive protein concentration.  Fifty 
four (29%) patients received adjuvant 5FU- based chemotherapy. 
Fifty five patients (29%) presented as emergencies.  Of those patients who presented 
as an emergency 10 patients presented with blood loss, 31 patients with obstruction and 14 
patients presented with perforation.  In the emergency group, tumour stage was greater 
(p<0.001), more patients received adjuvant therapy (p<0.01), more patients had an elevated 
mGPS (p<0.01) and more patients died of their disease (p<0.05).  An elevated mGPS did not 
vary with the proportion of patients presenting with blood loss, obstruction or perforation.  
The minimum follow-up was 12 months; the median follow-up of the survivors was 
48 months. Cancer specific survival was 85% and 62% at 3 years in the elective and 
emergency groups respectively (Table 2).  Emergency presentation was associated with 
poorer 3 year cancer specific survival in those patients aged 65-74 years (p<0.01), males and 
females (p<0.05), in the deprived (p<0.01), in TNM stage II (p<0.01), in no adjuvant therapy 
(p<0.01) disease and in the mGPS 0 and 1 (p<0.05) groups (Table 2). 
Non-cancer survival was 90% and 92% at 3 years in the elective and emergency 
groups respectively (Table 3).  Emergency presentation was not significantly associated with 
poorer 3 year non-cancer specific survival in any of the factors examined. 
Survival analysis of those patients undergoing potentially curative surgery for TNM 
stage II colon cancer is shown in Table 4.  On univariate analysis, emergency presentation 
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(p<0.01), age (p<0.10), sex (p<0.10) and the mGPS (p<0.05) were associated with cancer 
specific survival.  On multivariate analysis including emergency presentation, age, sex, 
deprivation, adjuvant chemotherapy and the mGPS and as covariates, emergency presentation 
(p<0.05) and the mGPS (p<0.05) were independently associated with cancer specific survival 
(Table 4).  
On univariate analysis of the above factors and non-cancer survival, emergency 
presentation (p= 0.8574), age (p= 0.2296), sex (p= 0.1946), deprivation (p= 0.1648), adjuvant 
chemotherapy (p= 0.2828) and the mGPS (p= 0.3372) did not show a significant association. 
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Discussion 
In the present study, in patients undergoing potentially curative surgery for colon 
cancer, emergency presentation was associated with poorer cancer specific survival, 
independent of TNM stage.  The percentage of patients with colon cancer presenting as an 
emergency (29%) in the present study over the period of 1999-2006 is in line with that (39%) 
previously reported in a large audit of colorectal cancer in the central belt of Scotland between 
1991-1994 (4).  Also, these results are consistent with our previous study of approximately 
2,000 patients which showed that, even after excluding deaths within 30 days of surgery, 
emergency presentation was independently associated with poorer cancer specific survival (5).   
We have also shown that emergency presentation is associated with the presence of a 
systemic inflammatory response prior to surgery, as evidenced by the mGPS.  However, on 
multivariate survival analysis in patients TNM stage II disease, both emergency presentation 
and an elevated mGPS were significant independent predictors of cancer specific survival.  
Therefore, it would appear that not all of the deleterious impact of emergency presentation on 
cancer specific survival can be accounted for by the presence of a systemic inflammatory 
response prior to surgery (5).   
It has been recognised for some time that pre-operative hypoalbuminaemia is 
associated with poor outcome following surgery (15,16).  Similarly, hypoalbuminaemia has 
been associated with poor long term outcome following surgery for colorectal cancer (17-19).  
In the past, this hypoalbuminaemia has been thought to be the result of nutritional depletion 
secondary to the tumour.  However, it has been postulated that the reduction in albumin 
concentration is secondary to the presence of a systemic inflammatory response, as evidenced 
by elevated circulating concentrations of C-reactive protein (20).  In the present study of the 34 
patients with hypoalbuminaemia, 30 (88%) had an elevated C-reactive protein concentration.  
This is consistent with results reported in other gastrointestinal tumours (21-23) and is consistent 
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with concept that the systemic inflammatory response is a major determinant of albumin 
concentrations in patients with cancer.  It may be that the presence of a chronic systemic 
inflammatory response, with its increased demand for specific amino acids for acute phase 
protein synthesis, promotes the degradation of available body protein including albumin 
(24,25,21).  There is also a consistent link between the presence of a systemic inflammatory 
response and comorbid disease (26).  Therefore, albumin may not only reflect underlying 
nutritional status but also comorbid disease. 
 The basis of the independent relationship between an elevated mGPS prior to surgery 
and poor long term survival in patients with primary operable colon cancer is not clear.  A 
plausible explanation is that an elevated mGPS may reflect compromised cell mediated 
immunity since an elevated C-reactive protein and hypoalbuminaemia are associated with 
lymphocytopenia(27) and an impaired T-lymphocytic response in the tumour (28).  Furthermore, 
the presence of an elevated C-reactive protein concentration and hypoalbuminaemia have also 
been shown to be associated with upregulation of components of innate immune system, 
including complement and macrophage function (29,30).  Therefore, these results would suggest 
that immune function is compromised prior to surgery, resulting in disease progression and 
poorer long term survival. 
 It is of interest to speculate on the temporal relationship between these events.  Does 
the tumour stage lead to emergency presentation and to a systemic inflammatory response and 
therefore primarily determines poorer cancer specific survival?  Alternatively, does the 
systemic inflammatory response lead to emergency presentation and poor survival?  In the 
present study, emergency presentation was associated with both increased T stage and an 
increased mGPS.  However, there was no difference in nodal involvement between the 
elective and emergency groups.  It may therefore be that the latter explanation is more likely; 
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namely that a systemic inflammatory response leads to emergency presentation, impaired host 
immune response and poor cancer specific survival.  
 In summary, the results of the present study suggest that emergency presentation and 
the presence of systemic inflammatory response prior to surgery are associated and the 
systemic inflammatory response may account, in part, for the deleterious effect of emergency 
presentation on cancer specific survival in patients undergoing potentially curative surgery for 
colon cancer.  Both emergency presentation and an elevated mGPS should be taken into 
account when assessing likely outcome of these patients. 
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Table 1.  Clinicopathological characteristics in patients undergoing potentially curative 
surgery for colon cancer according to mode of presentation (n= 188). 
 Elective 
n= 133 (%) 
Emergency 
n= 55 (%) 
p-value 
Age group    <65 years 
                      65-74 years 
                      >75 years 
34 (26) 
48 (36) 
51 (38) 
20 (36) 
17 (31) 
18 (33) 
 
 
0.204 
Sex   Male 
         Female 
68 (51) 
65 (49) 
33 (60) 
22 (40) 
 
0.268 
Deprivation  Affluent (1, 2) 
                     Intermediate (3, 4, 5) 
                     Deprived (6, 7) 
3 (2) 
54 (41) 
76 (57) 
0 (0) 
18 (33) 
37 (67) 
 
 
0.142 
Tumour    T1 
                 T2 
                 T3 
                 T4 
3 (2) 
14 (10) 
78 (59) 
38 (29) 
0 (0) 
1 (2) 
24 (44) 
30 (55) 
 
 
 
<0.001 
Nodal involvement  N0 
                                 N1 
                                 N2 
83 (62) 
36 (27) 
14 (11) 
26 (47) 
21 (38) 
8 (15) 
 
 
0.086 
TNM stage    I 
                      II 
                      III 
15 (11) 
68 (57) 
50 (38) 
0 (0) 
27 (49) 
28 (51) 
 
 
0.013 
Adjuvant therapy    No 
                                Yes 
103 (77) 
30 (23) 
31 (56) 
24 (44) 
 
0.004 
mGPS    0 
              1 
              2 
63 (47) 
54 (41) 
16 (12) 
16 (29) 
26 (47) 
13 (24) 
 
 
0.009 
    
Died    cancer 
            non-cancer 
26 (61) 
17 (39) 
21 (88) 
3 (12) 
 
0.021 
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Table 2. Cancer specific survival at 3 years in patients undergoing curative resection for colon 
cancer by mode of presentation (n= 188). 
 Elective 
n= 133 
% (SE) 
Emergency 
n= 55 
% (SE) 
p-value 
Age group    <65 years 
                      65-74 years 
                      >75 years 
94 (4) 
87 (5) 
76 (6) 
81 (10) 
50 (14) 
51 (14) 
0.1045 
0.0026 
0.1019 
Sex   Male 
         Female 
82 (5) 
87 (4) 
57 (10) 
70 (10) 
0.0242 
0.0214 
Deprivation  Affluent (1, 2) 
                     Intermediate (3, 4, 5) 
                     Deprived (6, 7) 
67 (27) 
80 (6) 
89 (4) 
 
57 (12) 
65 (9) 
 
0.0753 
0.0019 
TNM stage    I 
                      II 
                      III 
100 (0) 
92 (4) 
71 (7) 
 
64 (11) 
60 (10) 
 
0.0010 
0.4337 
Adjuvant therapy    No 
                                Yes 
85 (4) 
83 (7) 
60 (10) 
65 (11) 
0.0017 
0.2006 
mGPS    0 
              1 
              2 
90 (4) 
86 (5) 
59 (13) 
71 (13) 
56 (11) 
66 (17) 
0.0009 
0.0224 
0.3946 
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Table 3.  Non-cancer survival at 3 years in patients undergoing curative resection for colon 
cancer by mode of presentation (n= 188). 
 Elective 
n= 133 
% (SE) 
Emergency 
n= 55 
% (SE) 
p-value 
Age group    <65 years 
                      65-74 years 
                      >75 years 
100 (0) 
90 (5) 
83 (6) 
100 (0) 
81 (12) 
92 (7) 
0.4795 
0.4820 
0.2944 
Sex   Male 
         Female 
93 (3) 
88 (4) 
96 (4) 
85 (10) 
0.3046 
0.8795 
Deprivation  Affluent (1, 2) 
                     Intermediate (3, 4, 5) 
                     Deprived (6, 7) 
100 (0) 
91 (4) 
90 (4) 
 
84 (10) 
96 (3) 
 
0.9585 
0.2199 
TNM stage    I 
                      II 
                      III 
93 (6) 
91 (4) 
89 (5) 
 
86 (8) 
100 (0) 
 
0.8572 
0.1192 
Adjuvant therapy    No 
                                Yes 
88 (4) 
100 (0) 
86 (8) 
100 (0) 
0.7119 
 
mGPS    0 
              1 
              2 
91 (4) 
94 (4) 
72 (14) 
89 (10) 
95 (5) 
89 (10) 
0.9669 
0.4626 
0.1928 
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Table 4.  Clinicopathological characteristics and cancer specific survival in patients 
undergoing potentially curative surgery for TNM stage II colon cancer 
 Survival analysis    
 Univariate p-value Multivariate p-value 
 Hazard ratio 
(95% CI) 
 Hazard ratio 
(95% CI) 
 
Presentation (elective/ emergency) 4.57 (1.69-12.34) 0.0027 3.19 (1.14-8.93) 0.0270 
Age group (<65/ 65-74/ >75) 1.74 (0.91-3.33) 0.0930  0.3202 
Sex (male/ female) 0.36 (0.12-1.13) 0.0795  0.1027 
Deprivation 
(affluent/ intermediate/ deprived) 
 
1.48 (0.52-4.19) 
 
0.4626 
  
0.9784 
Adjuvant therapy (no/ yes) 0.33 (0.04-2.49) 0.2812  0.1985 
mGPS (0/ 1/ 2) 2.49 (1.23-5.06) 0.0116 2.22 (1.04-4.74) 0.0391 
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